MediTuner
About the company
MediTuner, founded at the Karolinska Institute, is a Swedish digital health company transforming respiratory care.
Our CE-marked, patented technology empowers patients with asthma and COPD (affecting 15% of the population) to monitor lung function, track symptoms, and receive instant, individualized treatment instructions.
Our unique algorithms also help clinicians intervene earlier, enabling patients to manage their condition more effectively. We tackle the challenges of poorly managed chronic respiratory diseases, which often lead to preventable hospitalizations and reduced quality of life.
Already reimbursed in Sweden, we are expanding across the Nordics, Europe, and beyond. Large real-world implementations in Swedish primary care have demonstrated improved clinical outcomes while halving unplanned healthcare visits.
By combining digital therapeutics, predictive analytics, and seamless integration with healthcare systems, MediTuner turns reactive asthma care into proactive care. Recognized as ‘Best Digital Technology for Asthma’ by 45 European patient organizations, we are setting a new standard for chronic respiratory disease management.
Quick links:
Medituner | LinkedIn
Contact:
Eric Alhanko, CEO
eric.alhanko@medituner.se
Capital need and valuation:
Capital Need: €2,000,000
Pre-Money Valuation: €8,000,000
Use of Funds
Scale sales to achieve cash-flow positivity
Financial forecast
Estimated Turnover 2025/2026: €1,000,000/€1,800,000
Revenue Model: Subscription sales with healthcare as payors